Oncor regulatory update

ONC (Gaithersburg, Md.) received permission from the FDA to export its investigational in vitro diagnostic genetic test systems for HER-2/neu and chronic myelogenous leukemia (CML) Mbcr/abl to Austria, Switzerland and Ireland. Applications are pending for permission to export the systems to other European countries. ...